Keros Therapeutics, Inc. (KROS)
19.27
-0.19
(-0.98%)
USD |
NASDAQ |
Jan 23, 14:30
Keros Therapeutics Research and Development Expense (TTM): 157.36M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amicus Therapeutics, Inc. | 142.29M |
| MannKind Corp. | 49.90M |
| Insmed, Inc. | 695.91M |
| Innoviva, Inc. | 29.71M |
| CorMedix, Inc. | 12.46M |